Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (29)
- Engineering (18)
- Biomedical Engineering and Bioengineering (16)
- Cell and Developmental Biology (15)
- Biotechnology (14)
-
- Cell Biology (14)
- Genetics and Genomics (11)
- Medical Sciences (9)
- Biochemistry, Biophysics, and Structural Biology (8)
- Genetics (8)
- Molecular Biology (8)
- Bioelectrical and Neuroengineering (7)
- Medical Biotechnology (6)
- Biochemistry (5)
- Biomedical (4)
- Electrical and Computer Engineering (4)
- Cancer Biology (3)
- Microbiology (3)
- Molecular, Cellular, and Tissue Engineering (2)
- Biophysics (1)
- Dermatology (1)
- Diseases (1)
- Genetic Processes (1)
- Hematology (1)
- Medical Biochemistry (1)
- Pediatrics (1)
- Research Methods in Life Sciences (1)
- Keyword
-
- Electroporation (10)
- Melanoma (7)
- Gene therapy (4)
- Plasmids (4)
- Ablation (3)
-
- Apoptosis (3)
- Immunotherapy (3)
- Irreversible electroporation (3)
- Plasmid DNA (3)
- Angiogenesis (2)
- DNA sensors (2)
- Disease models (2)
- Electrotransfer (2)
- Gene transfer techniques (2)
- IL-12 (2)
- Immune response (2)
- Mass spectrometry (2)
- Myeloid derived suppressor cells (2)
- Nanosecond pulsed electric fields (2)
- Pulsed electric fields (2)
- Treatment outcome (2)
- Tumor ablation (2)
- Tumor cells (2)
- Tumor microenvironment (2)
- A431 cells (1)
- Abscopal effect (1)
- Anthrax toxin receptor (1)
- Anti-cancer drug (1)
- Antieoplastic agents (1)
- Antimetabolites (1)
Articles 31 - 32 of 32
Full-Text Articles in Oncology
Il-12 Plasmid Delivery By In Vivo Electroporation For The Successful Treatment Of Established Subcutaneous B16.F10 Melanoma, M. Lee Lucus, Loree Heller, Domenico Coppola, Richard Heller
Il-12 Plasmid Delivery By In Vivo Electroporation For The Successful Treatment Of Established Subcutaneous B16.F10 Melanoma, M. Lee Lucus, Loree Heller, Domenico Coppola, Richard Heller
Bioelectrics Publications
Interleukin-12 (IL-12) has been used in numerous immunotherapy protocols against melanoma. However, delivery of IL-12 in the form of recombinant protein can result in severe toxicity, and gene therapy has had limited success against B16.F10 murine melanoma. The purpose of this study was to examine the effectiveness of in vivo electroporation for the delivery of plasmid DNA encoding IL-12 as an antitumor agent against B16.F10 melanoma. We treated mice bearing established B16.F10 melanoma tumors with intratumoral (i.t.) or intramuscular (i.m.) injections of a plasmid encoding IL-12, followed by in vivo electroporation. For i.t. treatments, we used an applicator containing six …
Electrically Mediated Plasmid Dna Delivery To Hepatocellular Carcinomas In Vivo, L. Heller, M. J. Jaroszeski, D. Coppola, C. Pottinger, R. Gilbert, Richard Heller
Electrically Mediated Plasmid Dna Delivery To Hepatocellular Carcinomas In Vivo, L. Heller, M. J. Jaroszeski, D. Coppola, C. Pottinger, R. Gilbert, Richard Heller
Bioelectrics Publications
Gene therapy by direct delivery of plasmid DNA has several advantages over viral gene transfer, but plasmid delivery is less efficient. In vivo electroporation has been used to enhance delivery of chemotherapeutic agents to tumors in both animal and human studies. Recently, this delivery technique has been extended to large molecules such as plasmid DNA. Here, the successful delivery of plasmids encoding reporter genes to rat hepatocellular carcinomas by in vivo electroporation is demonstrated.